Search

Lance W. Rider

Examiner (ID: 8345, Phone: (571)270-1337 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
662
Issued Applications
193
Pending Applications
1
Abandoned Applications
470

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5415787 [patent_doc_number] => 20090041674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'TARGETED IRON OXIDE NANPARTICLES' [patent_app_type] => utility [patent_app_number] => 12/280321 [patent_app_country] => US [patent_app_date] => 2007-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7022 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041674.pdf [firstpage_image] =>[orig_patent_app_number] => 12280321 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/280321
TARGETED IRON OXIDE NANPARTICLES Feb 13, 2007 Abandoned
Array ( [id] => 5120747 [patent_doc_number] => 20070142462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Method of Treating Cancer' [patent_app_type] => utility [patent_app_number] => 11/671199 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13773 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142462.pdf [firstpage_image] =>[orig_patent_app_number] => 11671199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/671199
Method of Treating Cancer Feb 4, 2007 Abandoned
Array ( [id] => 5079261 [patent_doc_number] => 20070122485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 11/650701 [patent_app_country] => US [patent_app_date] => 2007-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4455 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122485.pdf [firstpage_image] =>[orig_patent_app_number] => 11650701 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650701
Organic compounds Jan 7, 2007 Abandoned
Array ( [id] => 5367040 [patent_doc_number] => 20090304599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Protein Nanoparticles and the Use of the Same' [patent_app_type] => utility [patent_app_number] => 12/097560 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5447 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304599.pdf [firstpage_image] =>[orig_patent_app_number] => 12097560 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097560
Protein Nanoparticles and the Use of the Same Dec 19, 2006 Abandoned
Array ( [id] => 5100853 [patent_doc_number] => 20070184115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Modified release formulations of tramadol and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/640494 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 140064 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184115.pdf [firstpage_image] =>[orig_patent_app_number] => 11640494 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/640494
Modified release formulations of tramadol and uses thereof Dec 17, 2006 Abandoned
Array ( [id] => 4882689 [patent_doc_number] => 20080257021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Method of Making Dried Particles' [patent_app_type] => utility [patent_app_number] => 12/097788 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2633 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20080257021.pdf [firstpage_image] =>[orig_patent_app_number] => 12097788 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097788
Method of Making Dried Particles Dec 14, 2006 Abandoned
Array ( [id] => 5040165 [patent_doc_number] => 20070092447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'CONTRAST AGENT FOR COMBINED MODALITY IMAGING AND METHODS AND SYSTEMS THEREOF' [patent_app_type] => utility [patent_app_number] => 11/565786 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12733 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092447.pdf [firstpage_image] =>[orig_patent_app_number] => 11565786 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/565786
CONTRAST AGENT FOR COMBINED MODALITY IMAGING AND METHODS AND SYSTEMS THEREOF Nov 30, 2006 Abandoned
Array ( [id] => 5182490 [patent_doc_number] => 20070053834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Radioligands for the TRP-M8 receptor and methods therewith' [patent_app_type] => utility [patent_app_number] => 11/595006 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053834.pdf [firstpage_image] =>[orig_patent_app_number] => 11595006 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/595006
Radioligands for the TRP-M8 receptor and methods therewith Nov 7, 2006 Abandoned
Array ( [id] => 4964895 [patent_doc_number] => 20080107715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'PHARMACEUTICAL CONTAINING FOOD COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/556644 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7133 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107715.pdf [firstpage_image] =>[orig_patent_app_number] => 11556644 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/556644
PHARMACEUTICAL CONTAINING FOOD COMPOSITIONS AND USES THEREOF Nov 2, 2006 Abandoned
Array ( [id] => 4663192 [patent_doc_number] => 20080254099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease' [patent_app_type] => utility [patent_app_number] => 12/093423 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9569 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254099.pdf [firstpage_image] =>[orig_patent_app_number] => 12093423 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/093423
Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease Oct 26, 2006 Issued
Array ( [id] => 7550693 [patent_doc_number] => 08063026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides' [patent_app_type] => utility [patent_app_number] => 11/544244 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4577 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063026.pdf [firstpage_image] =>[orig_patent_app_number] => 11544244 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/544244
Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides Oct 5, 2006 Issued
Array ( [id] => 4943696 [patent_doc_number] => 20080081021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation' [patent_app_type] => utility [patent_app_number] => 11/540264 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8738 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081021.pdf [firstpage_image] =>[orig_patent_app_number] => 11540264 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/540264
Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation Sep 28, 2006 Abandoned
Array ( [id] => 5056324 [patent_doc_number] => 20070059246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability' [patent_app_type] => utility [patent_app_number] => 11/527710 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9197 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059246.pdf [firstpage_image] =>[orig_patent_app_number] => 11527710 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/527710
Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability Sep 26, 2006 Abandoned
Array ( [id] => 5215690 [patent_doc_number] => 20070104771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Transdermal galantamine delivery system' [patent_app_type] => utility [patent_app_number] => 11/525696 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11999 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104771.pdf [firstpage_image] =>[orig_patent_app_number] => 11525696 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/525696
Transdermal galantamine delivery system Sep 21, 2006 Abandoned
Array ( [id] => 5130690 [patent_doc_number] => 20070207087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes' [patent_app_type] => utility [patent_app_number] => 11/524771 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8640 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207087.pdf [firstpage_image] =>[orig_patent_app_number] => 11524771 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/524771
Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes Sep 20, 2006 Issued
Array ( [id] => 4859026 [patent_doc_number] => 20080267876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Nanoparticles for Targeted Delivery of Active Agent' [patent_app_type] => utility [patent_app_number] => 12/067510 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17091 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267876.pdf [firstpage_image] =>[orig_patent_app_number] => 12067510 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067510
Nanoparticles for Targeted Delivery of Active Agent Sep 19, 2006 Abandoned
Array ( [id] => 5074768 [patent_doc_number] => 20070014743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Subunguicide, and method for treating onychomycosis' [patent_app_type] => utility [patent_app_number] => 11/523508 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4623 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014743.pdf [firstpage_image] =>[orig_patent_app_number] => 11523508 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/523508
Subunguicide, and method for treating onychomycosis Sep 18, 2006 Abandoned
Array ( [id] => 5034137 [patent_doc_number] => 20070098676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'FUNCTIONALLY DIVERSE MACROMOLECULES AND THEIR SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 11/532342 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18348 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098676.pdf [firstpage_image] =>[orig_patent_app_number] => 11532342 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532342
FUNCTIONALLY DIVERSE MACROMOLECULES AND THEIR SYNTHESIS Sep 14, 2006 Abandoned
Array ( [id] => 5135672 [patent_doc_number] => 20070077301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Venlafaxine osmotic device formulation' [patent_app_type] => utility [patent_app_number] => 11/532186 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18976 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077301.pdf [firstpage_image] =>[orig_patent_app_number] => 11532186 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532186
Venlafaxine osmotic device formulation Sep 14, 2006 Abandoned
Array ( [id] => 10620630 [patent_doc_number] => 09339559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Targeted contrast agents and methods for targeting contrast agents' [patent_app_type] => utility [patent_app_number] => 11/530398 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 12547 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11530398 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/530398
Targeted contrast agents and methods for targeting contrast agents Sep 7, 2006 Issued
Menu